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Abstract

Purpose & Hypothesis

Operational Definitions

The Female Athlete Triad is a system of 3 components that afflicts up to
60% of female athletes (McArdle et al., 2015). The components have been
defined by the American College of Sports Medicine (ACSM) as low
energy availability, menstrual dysfunction, and low bone mineral density.
Due to the intense energy expenditure during training and the age at which
intense training begins in order to compete at the collegiate level, NCAA
Division I female athletes are at a heightened risk for the Female Athlete
Triad. This study used the LEAF-Q survey to collect risk assessment levels
from each participant. The purpose of this study was to examine the
prevalence of the Female Athlete Triad in NCAA Division I female athletes
using a large and diverse sample.

• The purpose of this study was to examine the prevalence of the Female
Athlete Triad risk factors in NCAA Division I colligate female athletes across a
broad and ethnically diverse sample.
• It was hypothesized that at least one Triad component would be prevalent in a
majority of NCAA Division I colligate female athletes. Additionally, it was
expected that the prevalence of the Triad would be higher than found in
previous studies on similar demographics due to the larger sample used.

Amenorrhea: Amenorrhea is characterized by the absence of three or more
consecutive menstrual cycles after menarche, the absence of a menstrual
cycles for 6 or more months, or no onset of a menstruation cycle by age 15
(Amenorrhea 2021).
Low Bone Mineral Density: Low bone mineral density is defined by the
ACSM as a bone mineral density (BMD) score (z-) of less than -1 (Bone
mass measurement: What the numbers mean 2018).
Low Energy Availability: Low energy availability (LEA) is calculated by
subtracting energy expenditure during exercise from daily energy intake,
divided by fat free mass (FFM) of the individual, in kilograms. A
measurement less than 30kcal/kg-FFM per day is considered at risk of LEA
(Torres-McGehee et al., 2020).
Menstrual Dysfunction: Bleeding and ovarian regularities such as
amenorrhea and oligomenorrhea (Cheng et al., 2021).
Osteoporosis: Bone mineral density more than 2.5 standard deviations below
the mean for an individual’s gender and age (Bone mass measurement:
What the numbers mean 2018).

Methodology

Introduction
•
•
•
•
•
•
•
•
•

Up to 60% of female athletes suffer from the Female Athlete Triad
(McArdle et al., 2015).
The Female Athlete Triad consists of the interrelation of low energy
availability (LEA), menstrual dysfunction, and low bone mineral density
(BMD) (McArdle et al., 2015; Brook et al., 2017). See the figure below.
Females presenting with LEA, hormone dysfunction, or low BMD, either
alone or in combination, are considered at risk of the consequences of
the Triad (Javed et al., 2013).
Weight-dependent sports have a higher incidence of the Triad’s
components (Doyle-Lucas et al., 2014).
LEA is prevalent in up to 58% of female athletes and can lead to the
other two Triad components: menstrual dysfunction and low BMD
(Logue et al., 2020).
Menstrual dysfunction is prevalent in 32% of female athletes (Cheng et
al., 2021).
Bone stress fractures occur in 34.3% of female collegiate athletes
(Thein-Nissenbaum et al., 2011).
Previous studies have not focused on NCAA Division I athletes.
There is a current need for a study with a large, well-diversified sample
in order to find an accurate estimate of the prevalence level.

•

Participants

Research
Design

Instrumentation

•
•

•
•
•

Quantitative, non-experimental, descriptive study
Online survey completed by all participants
Risk scores and subject characteristics obtained
from participants’ completed surveys

•

Low Energy Availability in Females
Questionnaire (LEAF-Q)
Score < 8: low risk for Female Athlete Triad
Score >8: high risk for Female Athlete Triad

•
•

Future Directions
• The results of this study may be helpful in creating intervention programs
for young female athletes to educate athletes of the risks and increase
early diagnosis of the Female Athlete Triad.
• This study was limited in its ability to clinically diagnose the components of
the Female Athlete Triad.
• Future studies should aim to clinically assess population for the
prevalence of the Female Athlete Triad.
• This could be done by measuring participants’ bone mineral density,
calculating the participants’ energy availability by documenting food intake
and energy expenditure over a several week time period, and
documenting menstrual irregularities over a several month time period.
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Data
Analysis
https://www.goldcrownfoundation.com/the-female-athlete-triad/

Inclusion criteria: biological female and current
NCAA Division I collegiate athlete
Voluntarily obtained from 10 universities
Completed Informed Consent form

•
•
•
•

Permission granted from Athletic Director of
each school
Questionnaire distributed to the 10 school’s
female athletes
Participants completed LEAF-Q.

Risk values were obtained from the LEAF-Q results
JASP was used to find descriptive statistics
Spearman's rho test was used to determine
correlations
Significance was set at an alpha level of 0.05
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